Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Curis and the Leukemia and Lymphoma Society agree to develop CUDC-907

Dec. 2, 2011

Novel caspase-3 activators and apoptosis inducers reported in patent literature

Dec. 2, 2011

Novel PI3K and mTOR inhibitors patented by Spanish researchers

Dec. 2, 2011

Costimulatory fusion protein enhances activity of tumor vaccine in vivo

Dec. 2, 2011

First-in-human results presented on PRS-050 in patients with advanced solid malignancies

Dec. 2, 2011

Idera Pharmaceuticals regains global rights to IMO-2055

Dec. 1, 2011

Merrimack Pharmaceuticals begins phase I study of MM-121 with multiple anticancer therapies

Dec. 1, 2011

Talon Therapeutics enrolls first patient in phase III Marqibo study

Dec. 1, 2011

Marina Biotech and Debiopharm select lead formulation for bladder cancer program

Dec. 1, 2011

New anticancer compounds described by Merck & Co.

Dec. 1, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...